Regulatory PathRegulatory requirements compared

Active substances

Budesonide + Formterol

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
BUFOMIX 160/4.5MCG EASYHALER160,4.5 µg,µgInhalation powder · Inhalation use1 InhalerSAR 158.00Generic · PrescriptionJazeera Pharmaceutical Industries (JPI)Valid
SYMBICORT 80 MCG/4.5 MCG TURBOHALER80,4.5 µg,µgInhalation powder · Inhalation use1 InhalerSAR 116.70NCE · PrescriptionAstraZenecaValid
SYMBICORT TURBUHALER160,4.5 µg,µgInhalation powder · Inhalation use1 InhalerSAR 169.80NCE · PrescriptionAstraZenecaValid
Indications — CHI Daman Drug Formulary

ASTHMA; CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD); GRAFT VERSUS HOST DISEASE

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.